Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:806-811
Published online before print February 9, 2006, doi: 10.1161/01.STR.0000204354.06965.44
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/3/806    most recent
01.STR.0000204354.06965.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurl, S.
Right arrow Articles by Salonen, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurl, S.
Right arrow Articles by Salonen, J. T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Metabolic Syndrome
*Stroke
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Other Stroke Treatment - Medical
Right arrow Epidemiology

(Stroke. 2006;37:806.)
© 2006 American Heart Association, Inc.


Original Contributions

Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men

Sudhir Kurl, MD; Jari A. Laukkanen, MD; Leo Niskanen, MD, PhD; David Laaksonen, MD, PhD; Juhani Sivenius, MD, PhD; Kristiina Nyyssönen, PhD Jukka T. Salonen, MD, PhD, MScPH

From the Research Institute of Public Health (S.K., J.A.L., K.N., J.T.S.), University of Kuopio, Finland; the Research Institute of Public Health and Department of Internal Medicine (J.A.L., L.N., D.L.), University Hospital of Kuopio, Finland; Department of Neurology (J.S.), University Hospital of Kuopio and Brain Research and Rehabilitation Centre Neuron, Kuopio, Finland; and Department of Public Health and General Practice (J.T.S.), University of Kuopio, and the Jurilab Ltd, Kuopio, Finland.

Correspondence to Sudhir Kurl, Research Institute of Public Health, University of Kuopio, PO 1627, 70211 Kuopio, Finland. E-mail sudhir.kurl{at}uku.fi

Background and Purpose— The metabolic syndrome, a clustering of disturbed glucose and insulin metabolism, obesity and abdominal fat distribution, dyslipidemia, and hypertension is associated with cardiovascular diseases. The aim of this study was to examine the relationship of metabolic syndrome, as defined by National Cholesterol Education Program (NCEP) and World Health Organization (WHO) criteria, with the risk for stroke.

Methods— Population-based cohort study with an average follow-up of 14.3 years from eastern Finland. A total of 1131 men with no history of cardiovascular disease and diabetes at baseline participated. Sixty-five strokes occurred, of which 47 were ischemic strokes.

Results— Men with the metabolic syndrome as defined by the NCEP criteria had a 2.05-fold (95% CI, 1.03 to 4.11; P=0.042) risk for all strokes and 2.41-fold (95% CI, 1.12 to 5.32; P=0.025) risk for ischemic stroke, after adjusting for socioeconomic status, smoking, alcohol, and family history of coronary heart disease. Additional adjustment for ischemic changes during exercise test, serum low-density lipoprotein cholesterol, plasma fibrinogen, energy intake for saturated fats, energy expenditure of leisure time physical activity, and white blood cell count, the results remained significant. The risk ratios among men with metabolic syndrome as defined by the WHO criteria were 1.82 (95% CI, 1.01 to 3.26; P=0.046) for all strokes and 2.16 (95% CI, 1.11 to 4.19; P=0.022) for ischemic stroke. After further adjustment, the respective risks were 2.08 (95% CI, 1.12 to 3.87; P=0.020) and 2.47 (95% CI, 1.21 to 5.07; P=0.013).

Conclusion— The risk of any stroke is increased in men with metabolic syndrome, in the absence of stroke, diabetes and cardiovascular disease at baseline. Prevention of the metabolic syndrome presents a great challenge for clinicians with respect to stroke.


Key Words: diabetes mellitus • ischemic stroke • metabolic syndrome • prospective studies • risk factors • stroke




This article has been cited by other articles:


Home page
NeurologyHome page
B. Segura, M. A. Jurado, N. Freixenet, C. Falcon, C. Junque, and A. Arboix
Microstructural white matter changes in metabolic syndrome: A diffusion tensor imaging study
Neurology, August 11, 2009; 73(6): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N L Cabral, A R R Goncalves, A L Longo, C H C Moro, G Costa, C H Amaral, L A M Fonseca, and J Eluf-Neto
Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2 year community based study
J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Q. Qiao, T. Laatikainen, B. Zethelius, B. Stegmayr, M. Eliasson, P. Jousilahti, and J. Tuomilehto
Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts
Stroke, February 1, 2009; 40(2): 337 - 343.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. F. Arenillas, L. Ispierto, M. Millan, D. Escudero, N. Perez de la Ossa, L. Dorado, C. Guerrero, J. Serena, J. Castillo, and A. Davalos
Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke
Neurology, July 15, 2008; 71(3): 190 - 195.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Bokura, S. Yamaguchi, K. Iijima, A. Nagai, and H. Oguro
Metabolic Syndrome Is Associated With Silent Ischemic Brain Lesions
Stroke, May 1, 2008; 39(5): 1607 - 1609.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Stroke, April 1, 2008; 39(4): 1078 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
Metabolic Syndrome and Incident End-Stage Peripheral Vascular Disease: A 14-year follow-up study in elderly Finns
Diabetes Care, December 1, 2007; 30(12): 3099 - 3104.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. L. Air and B. M. Kissela
Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms
Diabetes Care, December 1, 2007; 30(12): 3131 - 3140.
[Full Text] [PDF]


Home page
NeurologyHome page
K. L. Furie and E. E. Smith
Metabolic syndrome: A target for preventing leukoaraiosis and age-related dementia?
Neurology, September 4, 2007; 69(10): 951 - 952.
[Full Text] [PDF]


Home page
StrokeHome page
J. F. Arenillas, M. A. Moro, and A. Davalos
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke, July 1, 2007; 38(7): 2196 - 2203.
[Full Text] [PDF]


Home page
haematolHome page
F. Dentali, E. Romualdi, and W. Ageno
The metabolic syndrome and the risk of thrombosis
Haematologica, March 1, 2007; 92(3): 297 - 299.
[Full Text] [PDF]


Home page
haematolHome page
C. Ay, T. Tengler, R. Vormittag, R. Simanek, W. Dorda, T. Vukovich, and I. Pabinger
Venous thromboembolism a manifestation of the metabolic syndrome
Haematologica, March 1, 2007; 92(3): 374 - 380.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-P. Empana, M. Zureik, J. Gariepy, D. Courbon, J. F. Dartigues, K. Ritchie, C. Tzourio, A. Alperovitch, and P. Ducimetiere
The Metabolic Syndrome and the Carotid Artery Structure in Noninstitutionalized Elderly Subjects: The Three-City Study
Stroke, March 1, 2007; 38(3): 893 - 899.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Opie
Metabolic Syndrome
Circulation, January 23, 2007; 115(3): e32 - e35.
[Full Text] [PDF]